Lv4
480 积分 2024-12-10 加入
Shifting the goalposts in obesity drug development
8天前
已完结
Effects of PDE10A inhibitor MK-8189 in people with an acute episode of schizophrenia: A randomized proof-of-concept clinical trial
8天前
已完结
Myostatin-targeting antibody protects lean mass during incretin-induced weight loss
10天前
已完结
Efficacy and safety of once-weekly subcutaneous zenagamtide, a novel unimolecular GLP-1 and amylin receptor agonist, in type 2 diabetes: a multicentre, randomised, parallel, double-blind, placebo-controlled, dose-finding, phase 2 trial
10天前
已完结
Efficacy and safety of once-daily oral zenagamtide, a novel unimolecular GLP-1 and amylin receptor agonist, in adults with type 2 diabetes: a multicentre, randomised, parallel, double-blind, placebo-controlled, dose-finding, phase 2 trial
10天前
已完结
Discovery ofLAS194046: A Potent and Selective pan-JanusKinase (JAK) Inhibitor with a Suitable Profile for Inhaled Administration
18天前
已完结
Discovery of 4-substituted pyrrolidone butanamides as new agents with significant antiepileptic activity
24天前
已完结
Characterization of [(3)H]ucb 30889 binding to synaptic vesicle protein 2A in the rat spinal cord
24天前
已完结
MCC950 alleviates seizure severity and angiogenesis by inhibiting NLRP3/ IL-1β signaling pathway-mediated pyroptosis in mouse model of epilepsy
1个月前
已完结
MCC950 alleviates seizure severity and angiogenesis by inhibiting NLRP3/ IL-1β signaling pathway-mediated pyroptosis in mouse model of epilepsy
1个月前
已完结
皖公网安备34019202002308
